Richard Hilker, DPM
Podiatrist · Fort Wayne, INNPI 1487637377
Payments from drug & device makers
What this record shows
This record is dominated by other: $2,800 of the $4,385 with a category attached, or 63.8%. Convatec Inc. accounts for 63.8% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2024 at $2,964 and has fallen 93.6% since, to $191 in 2025.
Across 47 payments — averaging $93.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$3K
- Organogenesis Inc.$385
- Smith+Nephew$253
- Kerecis Limited$168
- EKOS Corporation$106
- KCI USA, Inc.$94
- plus $579 from 17 others
What the payments were for
- Food & beverage$1,39832%
- Education$932%
- Gifts$942%
- Other$2,80064%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 1 | $2,800 |
| Organogenesis Inc. | 5 | $385 |
| Smith+Nephew | 10 | $253 |
| Kerecis Limited | 3 | $168 |
| EKOS Corporation | 1 | $106 |
| KCI USA, Inc. | 3 | $94 |
| Stryker | 1 | $94 |
| Rikco International, LLC | 2 | $93 |
| Paratek Pharmaceuticals, Inc. | 4 | $76 |
| Medtronic | 2 | $40 |
| Triad Life Sciences Inc. | 1 | $34 |
| Johnson & Johnson | 1 | $32 |
| Medline Industries LP | 2 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Globus Medical | 1 | $26 |
| Treace Medical Concepts, Inc. | 1 | $22 |
| Vertex | 1 | $19 |
| Solventum Corporation | 1 | $19 |
| Nabriva Therapeutics, PLC | 1 | $17 |
| Merck | 1 | $13 |
| Osiris Therapeutics Inc. | 1 | $13 |
| Orthofix Medical, Inc. | 1 | $12 |
| Zimmer Biomet | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$2,800
- PuraPly$124
- Puraply Antimicrobial$124
- Santyl$122
- Apligraf$110
- Dermagraft$110
- Puraply/Affinity/NuTech$110
- EKOSONIC$106
How this compares
$4,385 in reported general payments places this provider in the 70th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 80 | $2,754 |
| Doxycycline Hyclate | 55 | $783 |
| Ammonium Lactate | 17 | $472 |
| Mupirocin | 24 | $207 |
| Gabapentin | 19 | $140 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $96 |
| Cephalexin | 17 | $43 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Fort Wayne
- Townsen KenningtonFort Wayne$20K
- Matthew RobisonFort Wayne$7K
- Andrew RaderJasper$726K
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- James VestileTipton$44K
- Andrew KapsalisAvon$37K
- Scott HoffmanAvon$22K
- John RachoyMunster$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.